Results 171 to 180 of about 5,365,252 (221)

Electrifying long-haul freight trucks reduces societal costs in the United States. [PDF]

Nat Commun
Porzio J, McNeil W, Tong F, Moura S, Auffhammer M, Scown CD.   +5 more
europepmc   +1 more source

Synchronization‐Performance‐Oriented Frequency‐Domain Iterative Learning Control for Wafer and Reticle Stages

Asian Journal of Control, EarlyView.
ABSTRACT The synchronization accuracy between the wafer stage and reticle stage in lithography is critical to overlay and critical dimension uniformity. Existing iterative learning control (ILC) methods indirectly optimize synchronization via time‐domain errors, failing to balance low‐frequency tracking accuracy and high‐frequency noise suppression ...
Xin Zhou, Yuejing Qi, Zhipeng Wu, Wei Qi, Tianwei Xu   +4 more
wiley   +1 more source

Evidence of a cascading positive tipping point towards electric vehicles. [PDF]

Nat Commun
Mercure JF, Lam A, Buxton JE, Boulton CA, Akther A, Lenton TM.   +5 more
europepmc   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

British Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić, Marta Kučan Štiglić, Ana Jelaković, Bojan Jelaković, Dinko Vitezić   +4 more
wiley   +1 more source

Economic modeling of polygenic risk prediction of coronary artery disease in childhood. [PDF]

NPJ Cardiovasc Health
Bitar F, Zareef R, Ismaeel H, Abou-Karam R, Arabi M, Bulbul Z, Bitar FF, Fahed AC.   +7 more
europepmc   +1 more source

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

Economic burden of Sanfilippo syndrome in the United States. [PDF]

Arch Public Health
Ashby F, Park H, Svensson M, Heldermon CD.   +3 more
europepmc   +1 more source

Zuranolone: A case study in (regulatory) rush to judgement?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove, Milutin Kostic, Barbara Mintzes, Gianna D'Ambrozio, Allen Shaughnessy   +4 more
wiley   +1 more source

Cost-effectiveness of four contraceptive methods to avoid unintended pregnancy among adolescents in China: an analysis based on decision-tree model. [PDF]

Contracept Reprod Med
Luo W, Wang D, Zhang Z, Wang Y, Li R, Xu G, Zhou L.   +6 more
europepmc   +1 more source

Pharmacometric evaluation of pre‐referral rectal artesunate in children with severe malaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Parenteral artesunate is the preferred first‐line treatment for severe malaria. Pre‐referral rectal artesunate suppositories are recommended where parenteral treatment is inaccessible. In this study, we compared dihydroartemisinin exposure and model‐predicted early parasite clearance following rectal artesunate and intravenous artesunate in ...
Ayorinde Adehin, Marie A. Onyamboko, Caterina Fanello, Nicholas J. White, Nicholas P. J. Day, Richard M. Hoglund, Joel Tarning   +6 more
wiley   +1 more source